Summit Strategic Search
Sr Medical Director Global Hematology/Oncology
Summit Strategic Search, Princeton, New Jersey, us, 08543
Senior Medical Director, Global Hematology/Oncology
The Opportunity
A premier global specialty pharmaceutical organization is seeking a
Senior Medical Director
to spearhead clinical development within their innovative Hematology/Oncology pipeline. This organization is renowned for its commitment to high-unmet-need disease areas and is currently in a high-growth phase globally. This role is a critical link between early-stage discovery and late-stage global clinical execution.
Role Overview As a key medical leader, you will drive the strategy for a diverse portfolio of assets, including small molecules, biologics, and next-generation cell/gene therapies. You will provide the clinical vision for programs ranging from
First-in-Human (FIH) through Phase III , ensuring scientific excellence and patient safety on a global scale.
Location:
Hybrid (Greater NJ/NY Area)
Sector:
Specialty Pharma / Rare Disease / Oncology
Compensation:
$310,000 – $340,000 Base + Bonus + LTI
Key Responsibilities
Clinical Strategy:
Design and execute global Clinical Development Plans (CDPs) for multiple assets in the Hem-Onc space.
Medical Oversight:
Serve as the Lead Medical Monitor for global trials, ensuring compliance with GCP and international regulatory standards.
Translational Leadership:
Partner with Research and Biomarker teams to transition molecules successfully from discovery to Proof of Concept (POC).
Regulatory Interface:
Act as the primary medical SME for interactions with global health authorities (FDA/EMA) for IND and BLA/NDA submissions.
External Advocacy:
Cultivate high-level partnerships with Global Key Opinion Leaders (KOLs) and academic investigators.
Qualifications
Education:
MD required. Board Certification/Eligibility in Medical Oncology or Hematology is preferred.
Industry Experience:
5+ years of clinical development experience within Pharma or Biotech, with a proven track record in early-phase development.
Technical Breadth:
Hands-on experience with cell/gene therapy or antibody platforms; specific expertise in
Multiple Myeloma
is highly advantageous.
Leadership:
Demonstrated success leading matrixed, multicultural teams in a global environment.
Equal Opportunity Statement Our client is an equal opportunity employer and value diversity. They do not discriminate on the basis of race, religion, color, national origin, gender, gender identity or expression, sexual orientation, age, marital status, veteran status, disability status, or any other characteristic protected by applicable law.
#J-18808-Ljbffr
Senior Medical Director
to spearhead clinical development within their innovative Hematology/Oncology pipeline. This organization is renowned for its commitment to high-unmet-need disease areas and is currently in a high-growth phase globally. This role is a critical link between early-stage discovery and late-stage global clinical execution.
Role Overview As a key medical leader, you will drive the strategy for a diverse portfolio of assets, including small molecules, biologics, and next-generation cell/gene therapies. You will provide the clinical vision for programs ranging from
First-in-Human (FIH) through Phase III , ensuring scientific excellence and patient safety on a global scale.
Location:
Hybrid (Greater NJ/NY Area)
Sector:
Specialty Pharma / Rare Disease / Oncology
Compensation:
$310,000 – $340,000 Base + Bonus + LTI
Key Responsibilities
Clinical Strategy:
Design and execute global Clinical Development Plans (CDPs) for multiple assets in the Hem-Onc space.
Medical Oversight:
Serve as the Lead Medical Monitor for global trials, ensuring compliance with GCP and international regulatory standards.
Translational Leadership:
Partner with Research and Biomarker teams to transition molecules successfully from discovery to Proof of Concept (POC).
Regulatory Interface:
Act as the primary medical SME for interactions with global health authorities (FDA/EMA) for IND and BLA/NDA submissions.
External Advocacy:
Cultivate high-level partnerships with Global Key Opinion Leaders (KOLs) and academic investigators.
Qualifications
Education:
MD required. Board Certification/Eligibility in Medical Oncology or Hematology is preferred.
Industry Experience:
5+ years of clinical development experience within Pharma or Biotech, with a proven track record in early-phase development.
Technical Breadth:
Hands-on experience with cell/gene therapy or antibody platforms; specific expertise in
Multiple Myeloma
is highly advantageous.
Leadership:
Demonstrated success leading matrixed, multicultural teams in a global environment.
Equal Opportunity Statement Our client is an equal opportunity employer and value diversity. They do not discriminate on the basis of race, religion, color, national origin, gender, gender identity or expression, sexual orientation, age, marital status, veteran status, disability status, or any other characteristic protected by applicable law.
#J-18808-Ljbffr